Phase II trial of fludarabine phosphate in patients with head and neck cancer: a Southwest Oncology Group Study

Cancer Treat Rep. 1987 Dec;71(12):1313-4.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Arabinonucleotides / therapeutic use*
  • Carcinoma, Squamous Cell / drug therapy*
  • Drug Evaluation
  • Head and Neck Neoplasms / drug therapy*
  • Hematopoiesis / drug effects
  • Humans
  • Vidarabine Phosphate / adverse effects
  • Vidarabine Phosphate / analogs & derivatives
  • Vidarabine Phosphate / therapeutic use*

Substances

  • Arabinonucleotides
  • Vidarabine Phosphate
  • fludarabine phosphate